Neuropeptide Concentrations in the Cerebrospinal Fluid of Depressed Patients Treated with Electroconvulsive Therapy
- 2 January 1991
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 158 (1) , 59-63
- https://doi.org/10.1192/bjp.158.1.59
Abstract
The CSF concentrations of CRF, somatostatin and β-endorphin were determined in nine patients who fulfilled DSM–III criteria for major depression with psychotic features. CSF samples were obtained at baseline in the depressed state, and again after a course of ECT. Concentrations of both CRF and β-endorphin decreased after ECT, while the concentration of somatostatin increased, although the latter difference did not attain statistical significance. The increase in CSF concentrations of CRF and β-endorphin in depressed patients is therefore seen to be state-dependent.Keywords
This publication has 27 references indexed in Scilit:
- CSF Somatostatin in alzheimer's disease, depressed patients, and control subjectsBiological Psychiatry, 1988
- CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depressionBiological Psychiatry, 1988
- Platelet alpha 2-adrenoreceptor binding in elderly depressed patientsAmerican Journal of Psychiatry, 1985
- The present status of unilateral ECT: Some recommendationsJournal of Affective Disorders, 1984
- Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed PatientsScience, 1984
- CSF Somatostatin in Affective IllnessArchives of General Psychiatry, 1983
- Monitoring the Duration of Electroconvulsive Therapy SeizuresArchives of General Psychiatry, 1982
- A Specific Laboratory Test for the Diagnosis of MelancholiaArchives of General Psychiatry, 1981
- MECHANISM OF THE ANTIDEPRESSANT ACTION OF ELECTROCONVULSIVE THERAPYThe Lancet, 1978
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967